Carbapenem-producing Enterobacterales (CPE) pose a serious global health threat. This study aimed to develop a rapid and cost-effective ultraviolet (UV) spectrophotometry-based assay for detecting carbapenem resistance and identifying the carbapenemase enzyme category in Enterobacterales, thereby substantially reducing diagnostic turnaround times. The assay quantified Meropenem hydrolysis using ΔA = A300–A340 and was evaluated using 137 Enterobacterales strains. The hydrolysis level, measured by residual Meropenem after 3 h at 37 °C, was used to assess resistance. The A300–A340 method showed strong agreement with standard disk diffusion and VITEK-2 Compact results. Furthermore, the inhibitory effect of EDTA on Meropenem hydrolysis was tested on 79 CPE strains (35 MBL-producing and 44 non-MBL-producing) to differentiate carbapenemase categories, with PCR serving as the reference. A strong linear correlation (R2 = 0.9934) was observed between Meropenem concentration and ΔA. The assay demonstrated 98.54% accuracy in detecting Meropenem resistance using an 85% Meropenem retention threshold, and both the hydrolysis and inhibitor enhancement assays showed 97.47% specificity for distinguishing MBL from non-MBL producers. In conclusion, this UV spectrophotometry-based assay provides a rapid, accurate, and economical approach for detecting carbapenem resistance and classifying carbapenemase type, offering great potential for improving CPE infection management and guiding antibiotic therapy.
Tang et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: